Response-adaptive randomization in clinical trials: from myths to practical considerations (2020)

First Author: Robertson D

Attributed to: Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.48550/arxiv.2005.00564

Publication URI: https://arxiv.org/abs/2005.00564

Type: Preprint